Viewing StudyNCT06095583

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 7:40 PM
Last Modification Date: 2024-10-26 @ 3:11 PM
Study NCT ID: NCT06095583
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2023-10-09
Brief Title: Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer LS-SCLC
Sponsor: Shanghai Junshi Bioscience Co Ltd
Organization: Shanghai Junshi Bioscience Co Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Limited-stage Small Cell Lung Cancer LS-SCLC
Keywords: